- Investing Ideas
- /
- Global Potentially Undervalued Companies
Global Potentially Undervalued Companies
Results
35264
0 new
Companies with a Value score of at least 3, ordered by Value score
35,264 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
6929 | HK$3.83 | -24.5% | n/a | HK$3.2b | HK$9.06 | PE10.6x | E7.6% | n/a | Healthcare | ||
NTR | US$0.93 | 0.5% | 11.6% | US$209.9m | US$1.13 | PS8.2x | E67.3% | n/a | Pharmaceuticals & Biotech | ||
SIA | €136.72 | 1.3% | 32.2% | €106.4b | €180.58 | PE11.8x | E1.2% | 3.2% | Capital Goods | ||
CRR | €17.28 | 1.5% | 6.3% | €12.6b | €21.14 | PE12.2x | E6.7% | 3.0% | Consumer Retailing | ||
506 | HK$2.84 | -0.4% | 15.0% | HK$7.8b | HK$3.90 | PE9.4x | E5.9% | 4.5% | Food, Beverage & Tobacco | ||
461893 | DKK 300.00 | 0% | 0% | DKK 115.4b | DKK 386.93 | PE15.7x | E12.2% | 3.3% | Food, Beverage & Tobacco | ||
SOUTHBANK | ₹24.34 | -1.9% | -8.0% | ₹63.7b | ₹35.14 | PB0.7x | E8.3% | 1.2% | Banks | ||
532477 | ₹118.95 | -6.3% | 12.9% | ₹908.2b | ₹158.96 | PB0.9x | E6.5% | 3.0% | Banks | ||
AIBR.F | €5.14 | -13.6% | 23.9% | €11.2b | €6.46 | PB0.8x | E-15.7% | 5.5% | Banks | ||
HP | US$33.43 | 12.7% | -12.5% | US$3.2b | US$42.93 | PE9.7x | E5.6% | 5.0% | Energy | ||
ECVT | US$6.57 | -5.6% | -33.0% | US$772.2m | US$10.21 | PE13.7x | E28.5% | n/a | Materials | ||
9DE | zł19.40 | -5.8% | -5.8% | zł2.5b | zł28.12 | PE17.4x | E18.4% | 2.4% | Media | ||
MCB | US$53.88 | 5.5% | 60.6% | US$582.0m | US$66.38 | PB0.9x | E17.3% | n/a | Banks | ||
GLO | €18.14 | -6.8% | 14.4% | €532.5m | €25.34 | PE7.9x | E5.7% | 3.9% | Commercial Services | ||
2IVB | UK£8.90 | 6.6% | -52.6% | UK£967.3m | UK£21.26 | PS1.1x | E49.6% | 0% | Pharmaceuticals & Biotech | ||
X34 | US$6.70 | -1.5% | -16.8% | US$377.6m | US$8.15 | PB0.6x | E52.3% | n/a | Healthcare | ||
7PZ | zł9.75 | -4.3% | 12.4% | zł36.0b | zł12.33 | PE7.3x | E1.2% | 10.4% | Insurance | ||
0RL9 | €8.34 | -2.6% | 27.8% | €491.2m | €17.22 | PB0.5x | E9.7% | 7.7% | Banks | ||
ITAUCL | CL$10,257.00 | -3.2% | 20.7% | CL$2.2t | CL$14,000.00 | PB0.6x | E10.1% | 4.8% | Banks | ||
DCMD.F | CA$1.95 | -3.6% | -9.2% | CA$146.0m | CA$4.10 | PB3.6x | E137.5% | 0% | Commercial Services | ||
0RFW | €2.93 | 0.9% | -11.6% | €436.4m | €6.57 | PE10.4x | E15.8% | 3.4% | Software | ||
0O1O | €83.90 | -0.7% | 1.0% | €991.6m | €102.12 | PE21x | E8.6% | 1.0% | Pharmaceuticals & Biotech | ||
1FY | US$2.78 | -2.1% | -24.5% | US$1.1b | US$4.88 | PB1x | E59.5% | n/a | Media | ||
0O9B | €9.12 | 3.1% | -2.5% | €1.9b | €11.63 | PS2.1x | E50.7% | 2.0% | Pharmaceuticals & Biotech |